Tolazamide (1156-19-0)
DOI: https://doi.org/10.22427/NTP-DATA-DTXSID3021358
Study Results
Chronic Bioassay Level of Evidence
An overview of chronic evidence from Rats studies.
Rats |
View
|
View
|
An overview of chronic evidence from Mice studies.
Mice |
View
|
View
|
Genetic Toxicology
An overview of Genetic Toxicology Mammalian Cell Mutagenicity study conclusions related to Tolazamide (1156-19-0).
Mammalian Cell Mutagenicity |
View
|
An overview of Genetic Toxicology Mammalian Cell Cytogenetics study conclusions related to Tolazamide (1156-19-0).
Mammalian Cell Cytogenetics |
CA
|
SCE
|
|
|
An overview of Genetic Toxicology Bacterial Mutagenicity study conclusions related to Tolazamide (1156-19-0).
Bacterial Mutagenicity |
View
|
Citation Information
NTP. Tolazamide (1156-19-0). Chemical Effects in Biological Systems (CEBS). Research Triangle Park, NC (USA): National Toxicology Program (NTP).
Publications
TR-051
Bioassay of Tolazamide for Possible Carcinogenicity (CASRN 1156-19-0)
Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., and Mortelmans, K. Salmonella mutagenicity tests. IV. Results from the testing of 300 chemicals Environ. Molec. Mutagen. Vol. 11 (Suppl 12) (1988) 1-158
Study Data
Toxicity and Carcinogenicity Studies
Evaluation of the Chronic Toxicity and Carcinogenicity of Tolazamide (1156-19-0) in Male F344 Rats Exposed via Dosed Feed
Evaluation of the Chronic Toxicity and Carcinogenicity of Tolazamide (1156-19-0) in Female F344 Rats Exposed via Dosed Feed
Evaluation of the Chronic Toxicity and Carcinogenicity of Tolazamide (1156-19-0) in Male B6C3F1 Mice Exposed via Dosed Feed
Evaluation of the Chronic Toxicity and Carcinogenicity of Tolazamide (1156-19-0) in Female B6C3F1 Mice Exposed via Dosed Feed
Genetic Toxicology Studies
Genetic Toxicity Evaluation of Tolazamide in Salmonella/E.coli Mutagenicity Test or Ames Test. Study 352518